Radar · Sustainability Tech in China
Best Sustainability Tech Companies in China
The 527 best Sustainability Tech companies in China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Abogen Biosciences.
By Rohit KhannaTrends & Stories
527companies tracked
$5.8Bdisclosed funding
2unicorns
126have raised
China's Sustainability Tech sector is moving fast, and if you want to know where the money's actually going, you're looking at 527 companies tracked here, ranked by disclosed equity funding and the momentum behind recent raises. Total disclosed funding across the directory hits $5.8B, with two unicorns already in the mix and a global market forecast to scale from $16.2B (2022) to $122.7B by 2032, a 23.8% CAGR according to MarketsandMarkets. That's not a slow build. EV battery technology, next-generation EV platforms, and drive system innovations are the themes pulling capital right now, and the investor roster reflects it: Hillhouse, Qiming Venture Partners, and Shenzhen Capital Group are among the most active backers in this directory.
The funding distribution is uneven, which I think is the real story. Jiuzi New Energy sits at $30M while JBD has pulled $140M, and those gaps tell you something about where conviction is concentrating. The broader sector faces a structural drag too: the lack of clear green technology regulations keeps some capital on the sideline, a tension flagged recently around sustainability tech layoffs as companies recalibrate. But the demand drivers, low-carbon transition pressure, smart grid adoption, green tech scaling, aren't going anywhere. So the companies in this directory that have locked in institutional backing are positioned ahead of a market still finding its regulatory footing.
Sources & further reading
- ResearchAndMarkets.com
FLIAR INTELLIGENCE · SUSTAINABILITY TECH × CHINA
Our analysis of 293 Sustainability Tech companies
$38.4b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
293companies analysed
83%cloud-native stacks
2025funding peak (by rounds)
12unicorns
2018median founding year
476kcombined LinkedIn audience
91%of audience held by top 3
1companies hiring publicly (12 mo)
Ranked: Best Sustainability Tech companies in China
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Abogen Biosciences 🦄 Developer of mRNA-based therapeutics for cancer and infectious diseases 55Moat top 14%Patents top 17%Innovation top 22%Funding top 27% All 8 signals ▾Moattop 14% Patentstop 17% Innovationtop 22% Fundingtop 27% Talenttop 38% Marketbottom 44% Globalbottom 43% Techbottom 24% Moat: Editorial + unicorn rating 9/10 · IP moat: 157 patents Patents: 157 patents matched (strict assignee match) · 154 filings since 2022 vs 3 in 2017-21 rank vs industry peers · Fliar Intelligence Index 55/100 | $1.1B | 49 mo ago | Series C | — | 2019 | Dr InBev Co-Founder & Co-CEO | 157 patents mRNA and circular RNA therapeutics with lipid nanoparticle delivery systems | — |
| 2 | Clover Biopharma Developer of drugs to treat autoimmune, cancer and infectious diseases 67Funding top 13%Market top 25%Global top 44%Moat top 48% All 6 signals ▾Fundingtop 13% Markettop 25% Globaltop 44% Moattop 48% Newsbottom 32% Techbottom 24% Funding: Raised $400M across 8 rounds · 8 rounds over 14 yrs (0.6/yr) Market: 681 employees (top 2% of Life Sciences) · Serving 4 countries incl. United States, China, United Kingdom rank vs industry peers · Fliar Intelligence Index 67/100 | $400M | 2 mo ago | Public | 681 | 2007 | — | — | — |
| 3 | Londian Electrics Provider of electric metering devices | $356M | 86 mo ago | Late Stage | — | 1996 | Frank CEO | — | — |
| 4 | Chongho Bridge Rural financial services provider empowering communities in remote areas | $299M | 59 mo ago | Series D | 6,000 | 1996 | — | — | — |
| 5 | Hualan Bioengineering Chinese vaccine and blood products manufacturer | $293M | 69 mo ago | Public | 3,243 | 1992 | Jingsong Wang Founder & CEO | — | — |
| 6 | Ascletis Developer of small molecules for the treatment of multiple diseases 42Funding top 19%Product top 30%Moat top 31%Innovation top 34% All 10 signals ▾Fundingtop 19% Producttop 30% Moattop 31% Innovationtop 34% Talentbottom 49% Marketbottom 42% Growthbottom 42% Globalbottom 36% Techbottom 30% Newsbottom 24% Funding: Raised $255M across 5 rounds · 5 rounds over 15 yrs (0.3/yr) Product: 6 distinct product lines · Company stage: Series B rank vs industry peers · Fliar Intelligence Index 42/100 | $255M | 3 mo ago | Series B | 41 | 2011 | Jinzi Wu Founder & CEO | — | — |
| 7 | Beijing Mabworks Biotech Developer of anticancer therapies | $214M | 74 mo ago | Series C | 285 | 2003 | — | — | — |
| 8 | Zhonglai Manufacturer of solar cells and solar PV panels | $210M | 101 mo ago | Public | 3,918 | 2008 | — | 3 patents Low‑pressure solar thermal power generation and wolfberry‑based food flavoring technologies | 2 partnerships · 3 awards |
| 9 | Souzhou Ribo Life Science Developer of nucleic acid drugs based on RNA interference (RNAi) technology | $201M | 46 mo ago | Public | 228 | 2007 | Zicai Liang Founder | — | — |
| 10 | RecBio Developer of vaccines to prevent infectious disease | $172M | 66 mo ago | Public | — | 2012 | Yong Liu Founder & CEO | — | — |
| 11 | JBD Manufacturer of micro-LED displays 48Funding top 27%Talent top 28%Growth top 35%Moat top 42% All 7 signals ▾Fundingtop 27% Talenttop 28% Growthtop 35% Moattop 42% Marketbottom 36% Techbottom 36% Globalbottom 36% Funding: Raised $140M across 1 rounds · 1 rounds over 5 yrs (0.2/yr) Talent: Analyst team rating 5/5 · 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 48/100 | $140M | 7 mo ago | Series B | — | 2015 | Lei Zhang Co-Founder | — | 1 launch |
| 12 | Inspur Provider of cloud computing, data center, and enterprise software solutions | $109M | 69 mo ago | Public | 3,054 | 1983 | Sun Pishu Co-Founder & CEO | 14 patents Patents concentrated in its core technology | — |
| 13 | EcoCeres Provider of renewable fuels including sustainable aviation fuel and cellulosic ethanol 7Talent top 38%Funding top 42%Global bottom 36%Market bottom 29% All 7 signals ▾Talenttop 38% Fundingtop 42% Globalbottom 36% Marketbottom 29% Newsbottom 28% Techbottom 16% Growthbottom 10% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $108M · 2 rounds over 4 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 7/100 | $108M | 41 mo ago | Unfunded | — | 2021 | Philip Siu Co-Founder | — | 2 partnerships · 1 award |
| 14 | CanSino Biologics Developer of vaccines for the treatment of infectious diseases | $107M | 31 mo ago | Public | 2,291 | 2009 | Helen Mao Co-Founder | 115 patents Adenoviral vector vaccines and inhalable nucleic‑acid lipid nanoparticle delivery systems | — |
| 15 | Beijing Huanuotai Biomedical Technology Developer of vaccines for the treatment of infectious diseases | $104M | 26 mo ago | Series B | — | 2019 | Wang Hailong CEO | — | — |
| 16 | Argo Biopharma Developer of oligonucleotide therapeutics for various diseases | $104M | 31 mo ago | Series A | — | 2021 | Shiwei Xia Co-Founder | — | — |
| 17 | Evopoint Developer of therapeutics for multiple diseases | $97M | 27 mo ago | Series E | — | 2017 | Nianfeng Ju Co-Founder | — | — |
| 18 | MAXVAX Biotechnology Developer of vaccines for infectious diseases 57Funding top 22%Market top 40%Moat top 42%Talent bottom 49% All 5 signals ▾Fundingtop 22% Markettop 40% Moattop 42% Talentbottom 49% Globalbottom 36% Funding: Raised $84.8M across 3 rounds · 3 rounds over 8 yrs (0.4/yr) Market: 100 employees (top 20% of Life Sciences) rank vs industry peers · Fliar Intelligence Index 57/100 | $85M | 6 mo ago | Series D | 100 | 2016 | Dexiang Chen Founder | — | — |
| 19 | Clobotics Provides drone data management solutions | $84M | 63 mo ago | Series A | 11 | 2016 | Mads Rasmussen Managing director | — | — |
| 20 | Drug Farm Developer of a novel treatment for metabolic diseases | $83M | 37 mo ago | Series C | 118 | 2015 | Tong Li Co-Founder & CSO | — | — |
| 21 | Yunyinggu Technology Display drivers and IP licencing for display driver chips and circuit boards | $74M | 66 mo ago | Deadpooled | — | 2012 | Gu Jing Founder | — | — |
| 22 | Luzhu Biotech Developer of human vaccines and biological drugs for multiple diseases | $73M | 47 mo ago | Public | 129 | 2001 | Jian Kong CEO | — | — |
| 23 | Walvax Chinese vaccine manufacturer specializing in vaccines for meningitis and influenza | $73M | 142 mo ago | Public | 2,249 | 2001 | — | — | — |
| 24 | Ustar Biotechnologies Isothermal amplification kits for pathogen detection and genotyping of infectious diseases | $62M | 54 mo ago | Series E | 65 | 2005 | — | 31 patents Integrated microfluidic nucleic acid detection platforms for rapid CRISPR‑based diagnostics | — |
| 25 | Thermona Developer of RNA technology-based drugs to address various diseases | $60M | 47 mo ago | Series A | — | 2021 | Wei Wensheng Founder | — | — |
| 26 | Hope Medicine Developer of monoclonal antibodies for the treatment of multiple diseases | $56M | 28 mo ago | Series B | — | 2018 | Rui Xiao Co-Founder | — | — |
| 27 | Microquanta Developers of perovskite solar cells | $56M | 44 mo ago | Series D | — | 2015 | Buyi Yan Co-Founder | — | — |
| 28 | Zhimeng Biopharma Developer of drugs for the treatment of chronic hepatitis B (CHB) and related liver diseases | $49M | 67 mo ago | Series A | — | 2017 | Zhijun Zhang Co-Founder | 127 patents Small-molecule potassium channel modulators for epilepsy and neuroprotection | — |
| 29 | Zhongshu Guoneng Technology Provider of energy storage services | $48M | 48 mo ago | Seed | — | — | — | — | — |
| 30 | Yeelight Provider of app-based internet-connected smart bulbs | $47M | 53 mo ago | Series E | — | 2012 | Eric Jiang Co-Founder & CEO | — | — |
| 31 | yeelight Yeelight offers a series of smart and wireless LED lightning products. | $47M | 53 mo ago | Series E | 500 | 2012 | — | — | — |
| 32 | Frontier Biotechnologies Clinical stage pharmaceutical company developing AIDS treatment drug | $43M | 113 mo ago | Series C | 392 | 2002 | — | 31 patents RNAi therapeutics targeting specific disease-related genes for medical treatment | — |
| 33 | Beikang Medical Developer of NGS-based diagnostic solutions for neonatal | $37M | 73 mo ago | Public | 488 | 2010 | — | — | — |
| 34 | Jinko Solar Manufacturer of solar modules 80Patents top 10%Fin. health top 11%Innovation top 22%Market top 24% All 13 signals ▾Patentstop 10% Fin. healthtop 11% Innovationtop 22% Markettop 24% Techtop 34% Talenttop 39% Partnerstop 40% Producttop 42% Fundingtop 43% Moattop 44% Newstop 49% Globalbottom 47% Growthbottom 36% Patents: 1,575 patents matched (strict assignee match) · 1521 filings since 2022 vs 54 in 2017-21 Fin. health: Revenue ~$12.8B · Revenue 366.7x total funding rank vs industry peers · Fliar Intelligence Index 80/100 | $35M | 67 mo ago | Acquired | 46,511 | 2006 | Kangping Chen CEO | 1,575 patents Advanced silicon solar cell designs, back-contact modules, and manufacturing processes | 1 award |
| 35 | Jiuzi New Energy Provider of charging networks and energy storage systems for electric vehicles 29Funding top 34%Talent bottom 49%Global bottom 25% All 3 signals ▾Fundingtop 34% Talentbottom 49% Globalbottom 25% Funding: Raised $30.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 29/100 | $30M | 8 mo ago | Public | — | 2021 | Li Tao CEO | — | — |
| 36 | Carbon Block Carbon management software and consulting solutions | $23M | 46 mo ago | Series B | — | 2011 | Luhui Yan Founder & CEO | — | — |
| 37 | Starna Therapeutics Developer of RNA-based drugs for multiple diseases 29Funding top 34%Moat top 38%Talent bottom 49%Market bottom 37% All 5 signals ▾Fundingtop 34% Moattop 38% Talentbottom 49% Marketbottom 37% Globalbottom 36% Funding: Raised $22.1M across 2 rounds · 2 rounds over 5 yrs (0.4/yr) Moat: Editorial + unicorn rating 4/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 29/100 | $22M | 7 mo ago | Series B | — | 2021 | Rongkuan Hu Founder | — | — |
| 38 | Chengdu Wiskin Biomedical Technology Developer of drugs for the treatment of EBV-related tumors | $21M | 42 mo ago | Series A | — | 2021 | Yuquan Wei Co-Founder | — | — |
| 39 | Xiangji Technology Big data platform to analyze and process data | $18M | 26 mo ago | Series C | 20 | 2014 | Lin Zhong Co-Founder | 5 patents Flexible 3D forming equipment for shaping workpieces and ping‑pong training devices | — |
| 40 | Healrna Developer of nucleic acid drugs to treat various diseases | $15M | 39 mo ago | Seed | — | 2021 | Zhong Tianyi Co-Founder & CEO | — | — |
| 41 | Kemi Biopharmaceutical Developer of immunotherapeutics for oncology and infectious disease | $14M | 44 mo ago | Series A | — | — | Shi Yuenian Founder | — | — |
| 42 | YolTech Developer of gene editing and LNP delivery platforms for therapeutics 27Funding top 37%Moat top 42%Talent bottom 49%Market bottom 40% All 5 signals ▾Fundingtop 37% Moattop 42% Talentbottom 49% Marketbottom 40% Globalbottom 29% Funding: Raised $14.1M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) Moat: Editorial + unicorn rating 4/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 27/100 | $14M | 9 mo ago | Series B | — | 2021 | Yuxuan Wu Founder & CEO | — | — |
| 43 | Sunpure Provider of robotic solutions for cleaning and installing photovoltaic modules 27Growth top 45%Moat top 45%Funding top 50%Product bottom 45% All 10 signals ▾Growthtop 45% Moattop 45% Fundingtop 50% Productbottom 45% Marketbottom 41% Innovationbottom 38% Techbottom 37% Globalbottom 36% Patentsbottom 29% Newsbottom 24% Moat: Editorial + unicorn rating 4/10 · IP moat: 2 patents rank vs industry peers · Fliar Intelligence Index 27/100 | $14M | 28 mo ago | Series A | 100 | 2019 | — | 2 patents PV array connection bridge inspection and monitoring technology | 1 award |
| 44 | Guangzhou Langsheng Pharmaceutical Developer of therapeutics for reproductive health | $14M | 36 mo ago | Series C | 600 | 2003 | — | — | — |
| 45 | Zheda Energy Provider of smart power carbon asset management solutions for businesses | $14M | 43 mo ago | Series A | — | 2017 | Jiang Xuedong Co-Founder | — | — |
| 46 | I2Cool Developer of electricity-free passive radiative cooling technologies. 22Talent top 28%Growth top 45%Funding bottom 42%Tech bottom 35% All 6 signals ▾Talenttop 28% Growthtop 45% Fundingbottom 42% Techbottom 35% Globalbottom 29% Marketbottom 23% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 22/100 | $14M | 25 mo ago | Series A | 20 | — | Christopher Chao Co-Founder | — | — |
| 47 | Small EEL Provider of SaaS-based energy management platform | $11M | 40 mo ago | Series A | — | 2020 | Zhu Yueyang Founder | — | — |
| 48 | Weifulai Technology Provider of smart waste management solutions 55Market top 31%Funding top 47%Global bottom 29% All 3 signals ▾Markettop 31% Fundingtop 47% Globalbottom 29% Market: 300 employees (top 7% of High Tech) Funding: Raised $8.4M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) rank vs industry peers · Fliar Intelligence Index 55/100 | $8M | 3 mo ago | Series C | 300 | 2013 | — | — | — |
| 49 | CoClean Developer of a smart portable air purifier | $6M | 36 mo ago | Series B | 68 | 2015 | Fei Zhao Founder & CEO | — | — |
| 50 | Starpower Provider of decentralized energy storage system 29Talent top 38%Growth top 45%Funding bottom 42%Tech bottom 39% All 6 signals ▾Talenttop 38% Growthtop 45% Fundingbottom 42% Techbottom 39% Globalbottom 38% Marketbottom 34% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Growth: Web rank 5,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 29/100 | $4M | 17 mo ago | Seed | — | 2023 | Laser Ding CEO & Co-founder | — | — |
Top 12 Sustainability Tech companies in China
#1
Public · Chengdu, Sichuan Sheng · founded 2007 · 681 employees$400Mraised▾
Public · Chengdu, Sichuan Sheng · founded 2007 · 681 employees
Developer of drugs to treat autoimmune, cancer, and infectious diseases. The company has developed its proprietary Trimer-Tag technology to develop novel, trimerized fusion-protein therapies. The trimerized fusion proteins have been shown to have a much better binding and therapeutic response. The company's drug pipeline include SCB-808, in a ready-for-injection prefilled syringe formulation and SCB-313 for Oncology.
Fliar Intelligence Index™ 67how this company ranks against its industry peers
Funding
top 13%Market
top 25%Global
top 44%Moat
top 48%News
bottom 32%Tech
bottom 24%Funding: Raised $400M across 8 rounds · 8 rounds over 14 yrs (0.6/yr) · Last round Post IPO (Mar 2026)
Market: 681 employees (top 2% of Life Sciences) · Serving 4 countries incl. United States, China, United Kingdom
Global: Serving 4 countries incl. United States, China, United Kingdom · Investors from 3 countries beyond China
Audience (LinkedIn): 8k LinkedIn followers
Funding rounds
- Mar 2026Post IPO$3.6M
- Apr 2024Post IPO$320.7K
- May 2023Post IPO$48.9M
- Dec 2022Post IPO$64.4M
Investors
GL Ventures, Temasek, Delos Capital, Orbimed, Oceanpine Capital, Qiaojing Capital
Tech stack
PhpTengineSwiperJqueryHsts
#2
Series B · Hangzhou, Zhejiang · founded 2011 · 41 employees$255Mraised▾
Series B · Hangzhou, Zhejiang · founded 2011 · 41 employees
Developer of small molecules for the treatment of multiple diseases. It offers pipeline of drug candidates which include Ritonavir for Covid, Ravidasvir for HCV, ASC22 for HIV, ASC40 for NASH, acne, solid tumor, breast cancer, and others.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 19%Product
top 30%Moat
top 31%Innovation
top 34%Talent
bottom 49%Market
bottom 42%Funding: Raised $255M across 5 rounds · 5 rounds over 15 yrs (0.3/yr) · Last round Post IPO (Feb 2026)
Product: 6 distinct product lines · Company stage: Series B
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 10 curated direct competitors tracked
Funding rounds
- Feb 2026Post IPO$107.9M
- Jan 2017Series B$100M
- Dec 2015Series B$20M
- Sep 2015Series B$35M
Founders & team
Investors
CBC Group, Tasly, Pavilion Capital Partners, Goldman Sachs, Qianhai Equity Investment Fund, Hangzhou Binjiang Investment Holding
#3
Series D · Lanzhou, Gansu · founded 2016 · 100 employees$84.8Mraised▾
Series D · Lanzhou, Gansu · founded 2016 · 100 employees
Developer of vaccines for infectious diseases. It offers an adjuvant platform, recombinant protein expression platform, and mRNA platform for developing preventive and therapeutic vaccines for influenza vaccine, rabies vaccine, rotavirus vaccine, and herpes zoster vaccine.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Funding
top 22%Market
top 40%Moat
top 42%Talent
bottom 49%Global
bottom 36%Funding: Raised $84.8M across 3 rounds · 3 rounds over 8 yrs (0.4/yr) · Last round Series D (Dec 2025)
Market: 100 employees (top 20% of Life Sciences)
Moat: Editorial + unicorn rating 4/10 · Soonicorn · 10 curated direct competitors tracked
Funding rounds
- Dec 2025Series D—
- Jul 2024Series C$41.3M
- Feb 2024Series C$41.9M
- Jul 2022Series B—
Founders & team
Investors
China Life Insurance, Sherpa Healthcare Partners, Hillhouse, Xinshang Capital, Korea Investment Partners, Qianhai Ark Asset Management
#4
Series B · Pudong, Shanghai · founded 2015$140.4Mraised▾
Series B · Pudong, Shanghai · founded 2015
Manufacturer of micro-LED displays. It develops active-matrix inorganic microLED display chips and panels, which have wavelengths ranging from UV to IR. It also offers control circuit boards to drive those display chips. It also offers custom displays with custom wavelengths, resolution, pixel pitch, and brightness.
Fliar Intelligence Index™ 48how this company ranks against its industry peers
Funding
top 27%Talent
top 28%Growth
top 35%Moat
top 42%Market
bottom 36%Tech
bottom 36%Funding: Raised $140M across 1 rounds · 1 rounds over 5 yrs (0.2/yr) · Last round Series B (Oct 2025)
Talent: Analyst team rating 5/5 · 2 named leaders on record · 2 C-suite/founder profiles curated
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 2k LinkedIn followers
Activity (LinkedIn): 6 product launches · 1 partnerships · 1 awards (incl. Applied Materials and RayNeo) announced in 12 mo
Funding rounds
- Oct 2025Series B$140.4M
- Jun 2024Series A—
- Jun 2023Series A—
- Aug 2022Series A—
Founders & team
Investors
Cowin Capital, Eight Roads Ventures, Co-win Ventures, Painuo Capital, Luminous Ventures, Ant Group
Tech stack
Amazon CloudfrontAmazon Web ServicesBootstrapGoogle AnalyticsGsapJquery
#5
Series C · Hangzhou, Zhejiang · founded 2013 · 300 employees$8.4Mraised▾
Series C · Hangzhou, Zhejiang · founded 2013 · 300 employees
Provider of smart waste management solutions. Its offerings include a cloud-based waste sorting machine and AI and blockchain-powered data analytics software. Its solution covers the entire waste management life cycle from classification, cearing, transportation, recycling, reduction treatment, and operations mangement. It alo offers smart access control locks, QR-code based samrt cabinets, sensor embedded sanitizer dispensers, and waste recycling plants.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Market
top 31%Funding
top 47%Global
bottom 29%Market: 300 employees (top 7% of High Tech)
Funding: Raised $8.4M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) · Last round Series C (Mar 2026)
Global: Single-market focus (China)
Funding rounds
- Mar 2026Series C—
- Jun 2023Series B$8.4M
Investors
Zhejiang Chenghe Asset Management, Bojiang Capital
#6
Public · Shenzhen, Guangdong Province · founded 2021$30Mraised▾
Public · Shenzhen, Guangdong Province · founded 2021
Provider of charging networks and energy storage systems for electric vehicles. The company develops direct current fast charging stations integrated with energy storage. It is also advancing a smart energy cloud platform project. This platform aims to enable interaction between charging facilities and power grid systems using IoT technology. The company is also initiating research and development testing for digital payment solutions.
Fliar Intelligence Index™ 29how this company ranks against its industry peers
Funding
top 34%Talent
bottom 49%Global
bottom 25%Funding: Raised $30.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) · Last round Post IPO (Oct 2025)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Global: Single-market focus (China)
Funding rounds
- Oct 2025Post IPO$30M
Founders & team
#7
Series B · Suzhou, Jiangsu · founded 2021$22.1Mraised▾
Series B · Suzhou, Jiangsu · founded 2021
Developer of RNA-based drugs for multiple diseases. The company focuses on the development of innovative drugs and vaccines with RNA as the core for infectious diseases, tumor immunology, and metabolic diseases.
Fliar Intelligence Index™ 29how this company ranks against its industry peers
Funding
top 34%Moat
top 38%Talent
bottom 49%Market
bottom 37%Global
bottom 36%Funding: Raised $22.1M across 2 rounds · 2 rounds over 5 yrs (0.4/yr) · Last round Series B (Oct 2025)
Moat: Editorial + unicorn rating 4/10 · Soonicorn
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 417 LinkedIn followers
Funding rounds
- Oct 2025Series B$44M
- May 2022Series A$22.1M
- Dec 2021Angel—
Founders & team
Investors
LYFE Capital, Source Code Capital, Hony Capital, Hillhouse, Sherpa Healthcare Partners, Hua Chuang Capital
#8
Series B · Shanghai, Shanghai · founded 2021$14.1Mraised▾
Series B · Shanghai, Shanghai · founded 2021
Developer of gene editing and LNP delivery platforms for therapeutics. It focuses on creating novel tools for genome editing using metagenomics data. It develops in vivo gene-editing medicines for genetic, metabolic, cancer, and cardiovascular diseases. It is researching treatments for diseases such as familial hypercholesterolemia and hereditary transthyretin amyloidosis.
Fliar Intelligence Index™ 27how this company ranks against its industry peers
Funding
top 37%Moat
top 42%Talent
bottom 49%Market
bottom 40%Global
bottom 29%Funding: Raised $14.1M across 2 rounds · 2 rounds over 4 yrs (0.5/yr) · Last round Series B (Sep 2025)
Moat: Editorial + unicorn rating 4/10 · Soonicorn · 10 curated direct competitors tracked
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 3k LinkedIn followers
Funding rounds
- Sep 2025Series B$45M
- Nov 2023Series A$14.1M
- Feb 2022Angel—
- Series A—
Founders & team
Investors
Decheng Capital, Guangzhou Industrial Investment Group, Beijing Huafang Investment, K2VC, AstraZeneca
#9
Series C · Suzhou, Jiangsu · founded 2019$1.1Braised▾
Series C · Suzhou, Jiangsu · founded 2019
Developer of mRNA-based therapeutics for cancer and infectious diseases. The company has developed proprietary technology platforms in mRNA design, in vitro synthesis, and LNP-based delivery systems to develop targeted therapies for infectious and immuno-oncology indications.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Moat
top 14%Patents
top 17%Innovation
top 22%Funding
top 27%Talent
top 38%Market
bottom 44%Moat: Editorial + unicorn rating 9/10 · IP moat: 157 patents · Unicorn
Patents: 157 patents matched (strict assignee match) · 154 filings since 2022 vs 3 in 2017-21 · Latest publication 2026
Innovation: 157 patents (top 17% of patent-holders) · 154 filings since 2022 vs 3 in 2017-21
Funding rounds
- May 2022Series C—
- Nov 2021Series C$300M
- Aug 2021Series C$720M
- Apr 2021Series B$91.6M
Founders & team
Investors
SoftBank Vision Fund, 5Y Capital, Chimera, Mirae Asset, Fortune Ocean, Oriental Fortune Capital
#10
Series B · Beijing, Beijing · founded 2019$104.4Mraised▾
Series B · Beijing, Beijing · founded 2019
Developer of vaccines for the treatment of infectious diseases. The company specializes in the development and industrialization of human vaccine products and innovative adjuvants for COVID-19, influenza, malaria and herpes zoster.
Funding rounds
- Mar 2024Series B$84M
- Mar 2021Series A$20.4M
Founders & team
Investors
Fontus Capital, 3E BioVentures, Huayin Financial Investment, Watere Capital, Shunxi Venture Capital
#11
Series E · Suzhou, Jiangsu · founded 2017$97.3Mraised▾
Series E · Suzhou, Jiangsu · founded 2017
Developer of therapeutics for multiple diseases. It offers a drug pipeline that includes BLI inhibitors, EZH2 inhibitors, hURAT1 inhibitors, and antibody-drug conjugates for the treatment of cancer, infectious disease, and metabolic disease.
Funding rounds
- Feb 2024Series E$97.3M
Founders & team
Investors
Tencent, Tsinghua Holdings Capital, Jinan Industrial Development Investment Group, Chenhai Capital, Pudong Venture Capital, Yuekai Securities
#12
Seed · Hong Kong, Hong Kong · founded 2023$4.5Mraised▾
Seed · Hong Kong, Hong Kong · founded 2023
Provider of decentralized energy storage system. They specialize in designing advance energy network stability and sustainability through virtual power plant solutions. They offer a network connecting distributed energy devices through IoT,blockchain and AI.
Fliar Intelligence Index™ 29how this company ranks against its industry peers
Talent
top 38%Growth
top 45%Funding
bottom 42%Tech
bottom 39%Global
bottom 38%Market
bottom 34%Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Growth: Web rank 5,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo
Funding: Raised $4.5M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Seed (Jan 2025)
Funding rounds
- Jan 2025Seed$2.5M
- Jun 2024Seed$2M
Founders & team
Investors
Framework Ventures, Solana Ventures, Bitscale Capital, Alliance DAO, IoTeX, B1V
Tech stack
Amazon SesAmazon Web ServicesCore-JsGoogle Font ApiGoogle WorkspaceLeaflet
Funding & investor landscape
$5.8Btotal disclosed funding
75companies funded
129disclosed rounds
1rounds last 90 days
Most active investors
Qiming Venture Partners8 rounds
Notable founders
Jinzi Wu
Founder & CEO · Ascletis
Dexiang Chen
Founder · MAXVAX Biotechnology
Lei Zhang
Co-Founder · JBD
Qiming Li
Co-Founder & CEO · JBD
Li Tao
CEO · Jiuzi New Energy
Rongkuan Hu
Founder · Starna Therapeutics
Yuxuan Wu
Founder & CEO · YolTech
Dr InBev
Co-Founder & Co-CEO · Abogen Biosciences
Ying Bo
Co-Founder & Co-CEO · Abogen Biosciences
Wang Hailong
CEO · Beijing Huanuotai Biomedical Technology
Nianfeng Ju
Co-Founder · Evopoint
Meijie Le
CEO · Evopoint
Prism market signals · China · country-scoped Prism corpus, 3,939,605 docs
Market landscape — 10 sub-themes by coverage
Share of Sustainability Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH SIGNALS · China
How research on Climate Adaptation is moving in China
A read on the academic research around Climate Adaptation — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 883 China-affiliated papers.
research sentiment over time
200920202026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and intensifying — the enthusiastic (strongly-positive) share moved 0% → 12% across 2009–2026.
top research entities
- Chinese Academy of Sciences73
- Hohai University35
- Beijing Normal University30
- China Institute of Water Resources and Hydropower Research28
- University of Chinese Academy of Sciences26
leading researchers
Xinlong LE · Kun Guo · Guoru Huang · Mengmeng Hao · Qiang Ji · Xiaohong Chen · Zhaoli Wang · Zhaoyang Zeng
▲
Breakthroughs116 · 13%
▲ 0%→14% share
0 median citations91% since 2021mostly methods-led
Flood myth research is surging in Chinese climate adaptation breakthroughs — papers rose from 4 to 45, with Climate change newly entering at 46.
rising sub-themes (early→recent)
- Flood myth4→45
- Flooding (psychology)2→16
- Flood risk assessment1→9
- Urbanization2→5
- Flood mitigation1→4
Newly emergingClimate change 0→46 · Resilience (materials science) 0→21 · Climate model 0→13
Landmark What Is Nuisance Flooding? Defining and Monitoring an Emerging Challenge · 214 cites
◆
Advancements368 · 42%
▲ 40%→41% share
▲1.0× share momentum0 median citations82% since 2021mostly empirical
Climate change advancements are intensifying rapidly — Chinese institution papers grew from 4 to 130, with Climate risk newly emerging at 50.
rising sub-themes (early→recent)
- Climate change4→130
- Flood myth25→115
- Resilience (materials science)2→50
- China3→40
- Flooding (psychology)7→43
Newly emergingClimate risk 0→50 · Sustainability 0→22 · Climate resilience 0→17
Landmark Climate Change News Risk and Corporate Bond Returns · 517 cites
▼
Concerns240 · 27%
▼ 29%→27% share
▼0.9× share momentum0 median citations85% since 2021mostly empirical
Psychological resilience is a newly emerging concern — debuting at 32 papers alongside Flooding psychology rising from 2 to 27.
rising sub-themes (early→recent)
- Climate change7→133
- Resilience (materials science)2→38
- Flood myth9→45
- Flooding (psychology)2→27
- China4→22
Newly emergingClimate risk 0→36 · Psychological resilience 0→32 · Vulnerability (computing) 0→23
Landmark Addressing Challenges of Urban Water Management in Chinese Sponge Cities via Nature-Based Solutions · 178 cites
RESEARCH HOTSPOTS · China
Where climate adaptation is researched across China
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Beijing174 · +0.27
Shanghai90 · +0.28
Nanjing62 · +0.36
Guangzhou/Shenzhen62 · +0.41
Wuhan52 · +0.54
Hangzhou18 · +0.34
Harbin8 · +0.23
Common questions
How many Sustainability Tech companies are there in China?
Radar tracks 527 indexable Sustainability Tech companies headquartered in China that meet our profile-completeness bar.
What is the total funding raised by Sustainability Tech companies in China?
The Sustainability Tech companies in China on this list have raised a combined $5.8B in disclosed equity funding across 75 funded companies.
Which is the highest-funded Sustainability Tech company in China?
Abogen Biosciences is the highest-funded Sustainability Tech company in China, with $1.1B in disclosed equity funding.
How many Sustainability Tech companies in China are funded?
75 of the 527 Sustainability Tech companies in China on this list have disclosed at least one equity funding round.
How many Sustainability Tech unicorns are there in China?
2 Sustainability Tech companies in China on this list are valued at $1B or more.
Who are the top investors in China Sustainability Tech companies?
The most active investors in China Sustainability Tech companies on this list include Hillhouse, Qiming Venture Partners, Shenzhen Capital Group, Cowin Capital, Legend Capital.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.